123 related articles for article (PubMed ID: 2124131)
1. [Virological monitoring in subjects with HIV infection under treatment with zidovudine (AZT)].
Fiore JR; Angarano G; Fico C; Lo Caputo S; Fracasso C; Barile M; Pastore G
Boll Soc Ital Biol Sper; 1990 Jun; 66(6):601-6. PubMed ID: 2124131
[TBL] [Abstract][Full Text] [Related]
2. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons.
Dis Markers; 1990; 8(3):159-61. PubMed ID: 2125536
[No Abstract] [Full Text] [Related]
3. HIV-1 isolation from small amounts of whole blood: a technical evaluation.
Fiore JR; Angarano G; Fico C; Di Stefano M; Grottola A; Monno L; Fracasso C; Pastore G
Microbiologica; 1992 Jan; 15(1):35-44. PubMed ID: 1556958
[TBL] [Abstract][Full Text] [Related]
4. Serum p24 antigen levels in untreated and zidovudine-treated HIV-1 infected subjects.
Mulder JW; Lange JM; de Wolf F; Houweling JT; Bakker M; Coutinho RA; Goudsmit J
Neth J Med; 1990 Aug; 37(1-2):4-10. PubMed ID: 2120599
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of plasma viremia in HIV-infected patients under AZT treatment: a two-year follow-up study.
Ruffault A; Michelet C; Jacquelinet C; Guist'hau O; Genetet N; Bariou C; Colimon R; Cartier F
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):243-8. PubMed ID: 7788423
[TBL] [Abstract][Full Text] [Related]
6. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
7. HIV isolation from whole blood: a new approach to HIV detection.
Fiore JR; Angarano G; Fico C; Monno L; Carbonara S; Salamina GF; Fracasso C; Pastore G
Microbiologica; 1990 Oct; 13(4):311-5. PubMed ID: 2128364
[TBL] [Abstract][Full Text] [Related]
8. Viraemia and p24 antigenaemia are independent risk factors for the emergency of a zidovudine-resistant genotype in nucleoside analogue-treated HIV-1 infection.
Relimpio F; Rey C; Pineda JA; Leal M; Caruz A; Sánchez-Quijano A; Lissen E
Antivir Ther; 1997 Apr; 2(2):99-104. PubMed ID: 11322281
[TBL] [Abstract][Full Text] [Related]
9. Short-term evaluation of zidovudine-treated patients: decrease in plasma and cellular viraemia titres.
Tamalet C; Masquelier B; Ferchal F; Agut H; Puel J; Brun-Vézinet F; Fleury H; Rouzioux C
AIDS; 1992 Nov; 6(11):1403-4. PubMed ID: 1361750
[No Abstract] [Full Text] [Related]
10. [Dynamics of the antibody response and p24 antigenemia in HIV-1 infected individuals in Czechoslovakia].
Kopecká D; Brůcková M; Stanková M; Syrůcek L; Vojtĕchovský K; Petkov V
Cesk Epidemiol Mikrobiol Imunol; 1990 Mar; 39(2):65-73. PubMed ID: 2142624
[TBL] [Abstract][Full Text] [Related]
11. A killer mimotope with therapeutic activity against AIDS-related opportunistic micro-organisms inhibits ex-vivo HIV-1 replication.
Casoli C; Pilotti E; Perno CF; Balestra E; Polverini E; Cassone A; Conti S; Magliani W; Polonelli L
AIDS; 2006 Apr; 20(7):975-80. PubMed ID: 16603848
[TBL] [Abstract][Full Text] [Related]
12. Zidovudine and lamivudine: results of phase III studies.
Staszewski S
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S57. PubMed ID: 8595510
[TBL] [Abstract][Full Text] [Related]
13. Relationship between human immunodeficiency virus antigenemia and cytomegalovirus infection.
Lazzarotto T; Guan MX; Furlini G; Re MC; Ripalti A; Landini MP; La Placa M
Microbiologica; 1990 Jan; 13(1):61-5. PubMed ID: 2155377
[TBL] [Abstract][Full Text] [Related]
14. Circulating human immunodeficiency virus (HIV) p24 antigen-positive lymphocytes: a flow cytometric measure of HIV infection.
Ohlsson-Wilhelm BM; Cory JM; Kessler HA; Eyster ME; Rapp F; Landay A
J Infect Dis; 1990 Nov; 162(5):1018-24. PubMed ID: 1977803
[TBL] [Abstract][Full Text] [Related]
15. Acute decrease in HIV-1 viral load after initiation of zidovudine therapy: implications for interrupting vertical transmission.
Jackson JB
Pediatr AIDS HIV Infect; 1995 Dec; 6(6):358-9. PubMed ID: 11361462
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral efficacy and virological profile of a zidovudine/lamivudine/tenofovir disoproxil fumarate combination therapy in antiretroviral-naive patients.
Masquelier B; Neau D; Boucher S; Lavignolle-Aurillac V; Schrive MH; Recordon-Pinson P; Ragnaud JM; Fleury H
Antivir Ther; 2006; 11(6):827-30. PubMed ID: 17310827
[TBL] [Abstract][Full Text] [Related]
17. Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine, and indinavir during primary human immunodeficiency virus type 1 infection.
Smith D; Berrey MM; Robertson M; Mehrotra D; Markowitz M; Perrin L; Clumeck N; Lazzarin A; Burckhardt B; Weber R; Corey L; Cooper DA
J Infect Dis; 2000 Sep; 182(3):950-4. PubMed ID: 10950796
[TBL] [Abstract][Full Text] [Related]
18. Early and prolonged decrease of viremia in HIV-1-infected patients treated with didanosine.
Yerly S; Kaiser L; Baumberger C; Hirschel B; Perrin LH
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(4):358-64. PubMed ID: 7882100
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.
Oxenius A; Price DA; Günthard HF; Dawson SJ; Fagard C; Perrin L; Fischer M; Weber R; Plana M; García F; Hirschel B; McLean A; Phillips RE
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13747-52. PubMed ID: 12370434
[TBL] [Abstract][Full Text] [Related]
20. [New biological monitoring of HIV infection].
Morand-Joubert L
Rev Prat; 1998 Mar; 48(5):472-7. PubMed ID: 9781107
[No Abstract] [Full Text] [Related]
[Next] [New Search]
